Skip to content

Author

Laksh Kumar

We have 3 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

National trends in heart failure and hyperlipidemia related mortality in the United States, 1999–2024

Cardiovascular disease remains the leading cause of death in the United States, with heart failure (HF) and hyperlipidemia substantially contributing to mortality. This study aimed to examine national trends in HF-related mortality with coexisting hyperlipidemia from 1999 to 2024 and project future mortality patterns t...

B. Ayalew, D. N. Smith, Laksh Kumar et al. · 0 citations
Review Jul 2026

Efficacy and safety of lorundrostat in uncontrolled hypertension: a systematic review, meta-analysis, and meta-regression

Lorundrostat demonstrates significant antihypertensive efficacy and a manageable safety profile in UH patients and larger, long-term trials are warranted to further validate its safety across broader populations and complete its efficacy profile, emphasizing the unknown long-term cardiovascular outcomes of the interven...

Sumet Kumar, Arshia Arif Janjua, Laksh Kumar et al. · 0 citations
Open access Aug 2026

Mapping the national burden of cellulitis and related conditions in the United States, 1999–2024: a retrospective cohort analysis

Background: Cellulitis is a common bacterial skin infection associated with substantial morbidity and economic burden in the United States, yet long-term national mortality trends remain poorly characterized. Methods: We analyzed multiple cause-of-death data from CDC WONDER from 1999 through 2024 using ICD-10 codes L03...

A. Altamimi, Abdulrahman Mohammed Dahi, Yazeed S. Aljohani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.